Together Pharma Ltd reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was ILS 45.52 million compared to ILS 9.85 million a year ago. Net income was ILS 4.61 million compared to net loss of ILS 14.56 million a year ago.

Basic earnings per share from continuing operations was ILS 0.52. Diluted earnings per share from continuing operations was ILS 0.52.